Conversely, κ-OR antagonists prevent many effects of stress and counteract stress-induced behavioral responses and for this reason, are considered as novel therapeutics for stress-related disorders (Rorick-Kehn et al., 2014; Jacobson et al., 2020). This evidence concerns the gene OPRK1 and stress-related disorder.